Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane
Phase 2
Completed
- Conditions
- Septic Shock
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- Fresenius Medical Care France
- Target Recruit Count
- 24
- Registration Number
- NCT01067313
- Locations
- 🇫🇷
Edouard Herriot Hospital, P Reanimation, Lyon, France
News
No news found